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The need to develop new analytical methods for assurance of quality, safety and 
efficacy of drugs and pharmaceuticals is quite important because of their use not only as 
health care products but also life saving substances. The drug discovery process is rapidly 
evolving due to the technological developments in target identification, automation and 
chemical sciences. The bioanalytical methods assume of great importance due to i) 
development of new drugs ii) knowledge of the toxic potentials of the drugs at the early 
stages of developments and iii) understanding pharmacokinetic and metabolism 
characteristics of the selected compounds iv) setting up of threshold limits for new drugs 
by regulatory authorities. Keeping this in view, an attempt was made in the present 
investigation to develop new analytical methods for some of the important narcoleptics, 
antiretrovirals, antibiotics and anticonvulsant drugs. All the methods described in the 
thesis are simple, rapid, reliable and validated. The methods could be used not only for 
pharmacokinetics, pre-clinical and clinical trials but also for quality control and process 
development of bulk drugs. The work carried out in the present investigation was 
described in six chapters. 
 
CHAPTER 1 
Role of Bioanalytical Methods in Drug Discovery and Development 
Chapter 1 gives a brief introduction to the importance of bioanalytical methods in 
drug discovery and development. It explores the scientific knowledge in the different 
fields related to drug discovery such as chemical sciences, biological sciences and 
pharmacology, advanced automation and engineering technology. Modern analytical 
approaches to high-throughput drug discovery such as miniaturization, automation, 
robotics parallel separations, detection systems and chemometrics were discussed. 
Different terms in pharmacokinetics and analytical methodologies were presented. 
Statement of the problem, aims and objectives of the present investigation were given at 
the end of the chapter. All the experimental details were given in the respective chapters.   
 
CHAPTER 2 
Liquid Chromatography – Mass Spectrometric Studies of Novel Narcoleptics  
This chapter described the synthesis, characterization and liquid chromatography-
tandem mass spectrometry method development for the narcoleptic drugs and related 
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substances. Thirteen compounds (Fig. 1) were synthesized and characterized by 1HNMR 
and MS. Later the compounds were separated and determined by RP-HPLC. A Reversed 
phase C18 column (250 x 4.6 mm, particle size 5μm) was used. All the analytes were 
separated using acetonitrile and aqueous 0.02M ammonium acetate in gradient elution 
mode. Effects of buffer pH, temperature and different gradient programs were studied. 
The method was validated for impurity profiling and reaction monitoring in the synthesis. 
The developed RP-HPLC method was modified to LC-ESI-MS/MS for identification and 
structural elucidation of known as well as unknown by-products and degradation 
products. MS/MS fragmentation studies were completed in positive ion mode. The main 
advantage of the LC-MS/MS technique was on-line identification of the related 
substances without the need for time-consuming isolation and purification procedures. 
The developed method was found to be selective, sensitive, precise, linear, accurate and 
reproducible in determining adrafinil, modafinil and potential impurities which may br 
present at trace level in the finished products. Thus the method could be of use for 
process development as well as quality assurance of adrafinil and modafinil in bulk drugs 
as well as pharmaceutical formulations. It also finds application in optimization of 
reaction parameters to control formation of unwanted impurities in the synthesis. 
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Fig.1 Chemical structures of modafinil (MOSO, V), adrafinil (ADSO, IV) and related 
substances. 
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CHAPTER 3 
Enantiospecific resolution of narcoleptics by chiral HPLC 
In the present chapter, the enantiospecific resolution of R-modafinil and its 
synthetic intermediates was studied on Chiralcel OD-H and Chiralpak AD-H stationary 
phases. Different types of organic modifiers such as ethanol, 1-propanol and 2-propanol 
were used to resolve all the analytes. After a prolonged studies, the Chiralcel OD-H 
column was found to be more suitable than Chiralpak AD-H column. The effects of 
organic modifiers and of temperature on selectivity and resolution were studied. 
Optimum separation was obtained on a Chiralcel OD-H column with n-hexane-ethanol-
TFA (75:25:0.15 v/v/v) as a mobile phase at a flow rate 0.8 mL/min. Detection was 
carried out at 225nm using PDA detector. Effect of column temperature in the range of 
15-40°C on enantioselective retention of modafinil and related substances was studied. 
The separation was found to be enthalpy-driven process. The developed method was 
validated with respect to precision, accuracy, linearity, limits of detection and 
quantification. The developed method was suitable for both qualification of optical purity 
and isolation of individual enantiomers. It was also useful for the determination of chiral 
as well as achiral impurities during process development and in finished products.   
 
CHAPTER 4 
Development and Validation of LC and LC-MS Methods for Bioanalytical 
Applications of Novel Narcoleptics 
The present chapter contains three schemes of investigations. In the first scheme, 
a highly sensitive and specific method for the determination of adrafinil and its two 
metabolites was developed using liquid chromatography-tandem mass spectrometric 
detection. The developed method was sensitive and rapid for the simultaneous 
determination of adrafinil its metabolites viz., modafinil and modafinil acid in rat serum. 
The analysis time was 12 min. Under optimized conditions, LOD for all the analytes were 
in the range of 5.9-8.5ng/mL. Extraction of the analytes from the rat serum was carried 
out by solid phase extraction using Oasis HLB cartridges. The developed method was 
applied to the pharmacokinetic studies of adrafinil in rats. Serum was collected from rats 
at a regular interval of times after a single oral dose 20mg/kg of adrafinil.  
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The second investigation consists of the development of chiral HPLC method for 
rapid and sensitive analysis of adrafinil enantiomers in rat serum and urine. The samples 
were prepared using solid phase extraction (SPE). Te recovery was > 80%. Both the 
enantiomers were well resolved from each other (Rs > 6.8). The linearity range was 1.2-
500.0 μg/mL for both the enantiomers in serum and urine. The developed method was 
also useful for the enantiomeric determination of modafinil, which is an active metabolite 
of adrafinil. The limits of detection for R- and S-enantiomers of adrafinil were 1.05 and 
1.16 μg/mL. The optimized chiral-HPLC method was successfully used for 
pharmacokinetic studies of adrafinil in rats.  
Third section contains the enantioselective and simultaneous determination of R-
modafinil and its major metabolite, modafinil acid and modafinil sulphone in rat serum 
by normal-phase HPLC. Chiralcel OD-H column was used for the resolution and 
separation. The analytes were extracted by solid phase extraction using Oasis HLB 
cartridges. Recoveries were found > 90%. The assay was reliable, specific and has greater 
sensitivity, accuracy and linearity. The pharmacokinetic profile for single R-enantiomer 
and racemic modafinil was compared. The comparison study revealed that R-modafinil 
sustains higher plasma concentrations having half-life of 10-14h than that of racemic 
modafinil having half-life of 3-4h, which translated to longer maintenance of 
wakefulness. 
 
CHAPTER 5 
Development of on-line sample preparation techniques using restricted access 
medium (RAM) columns for determination of antibiotics and antiretrovirals in rats 
by LC and LC-MS 
This chapter was discussed in two sections. First chapter involves the development 
of a two dimensional liquid chromatography-tandem mass spectrometric method (2D-
LC-MS/MS) and its applications in pharmacokinetic studies of antiretroviral drugs such 
as abacavir, nevirapine and indinavir (Fig.2) in rats. In the preliminary study, LC-MS/MS 
system was evaluated using Inertsil ODS column. In off-line sample-cleanup, liquid-
liquid and solid phase extractions were tried. But these studies did not offered higher 
recoveries at low concentration of the drugs. Thus 2D-LC-MS/MS was adopted and 
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developed for the direct injection of rat serum. In the first dimension, a restricted access 
media (RAM) column was used for the removal of proteineous part of biological matrix 
and trapping of drug analytes. In second dimension, Inertsil ODS column was used for 
the separation and quantification of analytes. The optimized method was applied to in the 
pharmacokinetic study of antiretroviral drugs in Wistar rats. After a single oral dose of 
20mg/kg of each drug to healthy rats, blood and urine samples were collected at regular 
time intervals and analyzed by the developed method. 
Abacavir (ABC)  Indinavir (IDV)  Nevirapine (NVP) 
Fig.2 Chemical structures of ABC, NVP and IDV. 
 
Another rapid, sensitive and accurate HPLC method was developed and validated 
for determination of a antibiotic; rifaximin (Fig. 3) in rat serum and urine. The restricted 
access media (RAM) column enables the simple and rapid analysis without sample 
cleanup procedure, which avoided analyte losses and resulted in high reproducibility and 
reliability. Due to effective recoveries and reproducibilities the method would be suitable 
for the determination of rifaximin in clinical analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Chemical structure of rifaximin. 
 
 
 
 198
CHAPTER 6 
Development and validation of liquid chromatographic method for simultaneous 
determination of tramiprosate and vigabatrin in rats by fluorescence and 
evaporative light scattering detectors 
In the present study, anticonvulsant drugs such as tramiprosate and vigabatrin 
(Fig. 4) were determined and separated using liquid chromatography. Two methods with 
different detection systems using evaporative light scattering detector (ELSD) and 
fluorescence detector (FL) were developed and the results were compared with respect to 
linearity, sensitivity, accuracy, precision, limits of detection and quantification.  
 
Fig. 4 Chemical structures of tramiprosate and vigabatrin. 
  
 The developed liquid chromatographic-evaporative light scattering detection 
(HPLC-ELSD) method shows acceptable accuracy, precision and linearity values 
comparable to liquid chromatographic fluorescence (HPLC-FL) detection. The response 
of detector at low concentrations of analytes makes the later more suitable for the 
pharmacokinetic studies of tramiprosate. The derivatization process in HPLC-FL method 
although a time-consuming and tedious compared to direct injection of the analytes in 
HPLC-ELSD, its sensitivity (i.e. LOQ of 6 ng/mL) makes former method more reliable 
and sensitive. Thus the HPLC-FL method was used for the pharmacokinetic study of 
tramiprosate in rats. The analytes were separated from serum by precipitating protein 
matrix using acetic acid. The recovery was found to be > 88% for both the analytes. 
Linearity was studies in the range of 6-100ng/mL and 7-50ng/mL for tramiprosate and 
vigabatrin respectively. 
 
 
